Damaged packaging; BioNTech Corona Virus Vaccine in Hong Kong is Safe



UMMATIMES - The results of preliminary investigations conducted by BioNTech in Germany and Fosun Industrial found that the corona virus vaccine developed by BioNTech did not show any systemic factors during packaging. The investigation was carried out after the use of the BioNTech corona virus vaccine in Hong Kong and Macau this week was stopped.

The Hong Kong government in a written statement published on Saturday, March 27, 2021, stated that the results of the investigation found that the damage to the BioNTech corona virus vaccine packaging that was to be used by the Hong Kong community was likely due to environmental conditions during the long-distance transport process.

Damage to the packaging for the BioNTech corona virus vaccine that was sent to Hong Kong had nothing to do with cold temperatures and the logistics management of the corona virus vaccine. Through random testing sent to Hong Kong, there were no problems with the leakage of the corona virus vaccine.

Fosun and BioNTech assessed that the corona virus vaccine that was found damaged in the packaging section did not pose a safety risk and the people who were injected with the vaccine did not need to be alarmed.

The remainder of the next investigation will focus on ensuring the integrity of the intrinsic properties of the BioNTech corona virus vaccine, which was found to be damaged in packaging and ensuring that the vaccine delivered in one shipment is safe to use.

The Hong Kong government has assured that it will monitor Fosun and BioNTech to complete this investigation within a week so that Hong Kong can restart immunization of the corona virus vaccine.

The immunization of the corona virus vaccine in Hong Kong began in February 2021 and then used the Sinovac brand vaccine from China. In March 2021, Hong Kong began offering the public a vaccine developed by BioNTech from Germany.

However, on Wednesday, March 24, 2021, the authorities stopped using the corona virus vaccine developed by BioNTech due to damaged packaging. This condition has provoked confusion in the corona virus vaccine immunization centers across Hong Kong.